Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanine nucleotide-binding protein subunit alpha-14 is a member of the G protein alpha-q family (GNA14), functioning as part of the heterotrimeric G protein signaling complex. Upon activation of cell surface GPCRs, GNA14 facilitates GDP-GTP exchange and activates phospholipase C-beta, triggering hydrolysis of membrane phospholipids and release of intracellular messengers such as diacylglycerol (DAG) and inositol trisphosphate (IP3), resulting in activation of protein kinase C and calcium signaling. GNA14 is implicated in diverse physiological processes including platelet aggregation, cardiovascular regulation, glucose metabolism, and cell proliferation. It may play a role in disease states such as vascular tumors and cardiomyopathies, and pharmacological inhibition has demonstrated therapeutic potential in preclinical models.
Inhibition of GDP–GTP exchange to prevent downstream GNA14 signaling; Modulation of phospholipase C-beta and subsequent calcium/PKC signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine nucleotide-binding protein subunit alpha-14 (GNA14).